AAAAAA

   
Results: 1-9 |
Results: 9
STABILITY OF FREE AND TOTAL PROSTATE-SPECIFIC ANTIGEN IN SERUM FROM PATIENTS WITH PROSTATE CARCINOMA AND BENIGN HYPERPLASIA
Authors: PAUS E NILSSON O BORMER OP FOSSA SD OTNES B SKOVLUND E
Citation: E. Paus et al., STABILITY OF FREE AND TOTAL PROSTATE-SPECIFIC ANTIGEN IN SERUM FROM PATIENTS WITH PROSTATE CARCINOMA AND BENIGN HYPERPLASIA, The Journal of urology, 159(5), 1998, pp. 1599-1605
FECAL CALPROTECTIN CONCENTRATION IN PATIENTS WITH COLORECTAL-CARCINOMA
Authors: KRISTINSSON J ROSETH A FAGERHOL MK AADLAND E SCHJONSBY H BORMER OP RAKNERUD N NYGAARD K
Citation: J. Kristinsson et al., FECAL CALPROTECTIN CONCENTRATION IN PATIENTS WITH COLORECTAL-CARCINOMA, Diseases of the colon & rectum, 41(3), 1998, pp. 316-321
IMMUNOHISTOCHEMICAL CHARACTERIZATION OF 22 MONOCLONAL-ANTIBODIES AGAINST THE CA125 ANTIGEN - 2ND REPORT FROM THE ISOBM TD-1 WORKSHOP
Authors: NAP M VITALI A NUSTAD K BAST RC OBRIEN TJ NILSSON O SEGUIN P SURESH MR BORMER OP SAGA T DEBRUIJN HWA NOZAWA S KREUTZ FT JETTE D SAKAHARA H GADNELL M ENDO K BARLOW EH WARREN D PAUS E HAMMARSTROM S KENEMANS P HILGERS J
Citation: M. Nap et al., IMMUNOHISTOCHEMICAL CHARACTERIZATION OF 22 MONOCLONAL-ANTIBODIES AGAINST THE CA125 ANTIGEN - 2ND REPORT FROM THE ISOBM TD-1 WORKSHOP, Tumor biology, 17(6), 1996, pp. 325-331
SPECIFICITY AND AFFINITY OF 26 MONOCLONAL-ANTIBODIES AGAINST THE CA-125 ANTIGEN - FIRST REPORT FROM THE ISOBM TD-1 WORKSHOP
Authors: NUSTAD K BAST RC OBRIEN TJ NILSSON O SEGUIN P SURESH MR SAGA T NOZAWA S BORMER OP DEBRUIJN HWA NAP M VITALI A GADNELL M CLARK J SHIGEMASA K KARLSSON B KREUTZ FT JETTE D SAKAHARA H ENDO K PAUS E WARREN D HAMMARSTROM S KENEMANS P HILGERS J
Citation: K. Nustad et al., SPECIFICITY AND AFFINITY OF 26 MONOCLONAL-ANTIBODIES AGAINST THE CA-125 ANTIGEN - FIRST REPORT FROM THE ISOBM TD-1 WORKSHOP, Tumor biology, 17(4), 1996, pp. 196-219
FROM TISSUE POLYPEPTIDE ANTIGEN TO SPECIFIC CYTOKERATIN ASSAYS
Authors: BORMER OP
Citation: Op. Bormer, FROM TISSUE POLYPEPTIDE ANTIGEN TO SPECIFIC CYTOKERATIN ASSAYS, Tumor biology, 15(4), 1994, pp. 185-187
FROM TISSUE POLYPEPTIDE ANTIGEN TO SPECIFIC CYTOKERATIN ASSAYS
Authors: BORMER OP
Citation: Op. Bormer, FROM TISSUE POLYPEPTIDE ANTIGEN TO SPECIFIC CYTOKERATIN ASSAYS, Tumor biology, 15(4), 1994, pp. 185-187
EVALUATION OF SERUM CA-125 LEVEL AS A TUMOR-MARKER IN BORDERLINE TUMORS OF THE OVARY
Authors: MAKAR AP KAERN J KRISTENSEN GB VERGOTE I BORMER OP TROPE CG
Citation: Ap. Makar et al., EVALUATION OF SERUM CA-125 LEVEL AS A TUMOR-MARKER IN BORDERLINE TUMORS OF THE OVARY, International journal of gynecological cancer, 3(5), 1993, pp. 299-303
IS SERUM CA-125 AT THE TIME OF RELAPSE A PROGNOSTIC INDICATOR FOR FURTHER SURVIVAL PROGNOSIS IN PATIENTS WITH OVARIAN-CANCER
Authors: MAKAR AP KRISTENSEN GB BORMER OP TROPE CG
Citation: Ap. Makar et al., IS SERUM CA-125 AT THE TIME OF RELAPSE A PROGNOSTIC INDICATOR FOR FURTHER SURVIVAL PROGNOSIS IN PATIENTS WITH OVARIAN-CANCER, Gynecologic oncology, 49(1), 1993, pp. 3-7
SERUM CA-125 LEVEL ALLOWS EARLY IDENTIFICATION OF NONRESPONDERS DURING INDUCTION CHEMOTHERAPY
Authors: MAKAR AP KRISTENSEN GB BORMER OP TROPE CG
Citation: Ap. Makar et al., SERUM CA-125 LEVEL ALLOWS EARLY IDENTIFICATION OF NONRESPONDERS DURING INDUCTION CHEMOTHERAPY, Gynecologic oncology, 49(1), 1993, pp. 73-79
Risultati: 1-9 |